Ledger.Open graph →
SEC Form D · filed January 4, 2024

Remix Therapeutics, Inc

Offering
$90.0M
Sold
$13.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Kevin Bitterman · Cambridge, MADirectorPeter Smith · Centennial, COExec · DirectorRobert Gagnon · Watertown, MAExecMatthew Patterson · Dover, DEDirectorJeff Goater · Cambridge, MADirectorMichael Rome · New York, NYDirectorScott Biller · Watertown, MADirectorHeather Wasserman · Watertown, MAExecPeter Smith · New York, NYExec · DirectorRobert Gagnon · Watertown, MAExecMatthew Patterson · Dover, DEDirectorKevin Bitterman · Waltham, MADirectorJeff Goater · Cambridge, MADirectorMichael Rome · New York, NYDirectorScott Biller · Watertown, MADirectorHeather Wasserman · Watertown, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗